CA2000153A1 - Antidote - Google Patents

Antidote

Info

Publication number
CA2000153A1
CA2000153A1 CA2000153A CA2000153A CA2000153A1 CA 2000153 A1 CA2000153 A1 CA 2000153A1 CA 2000153 A CA2000153 A CA 2000153A CA 2000153 A CA2000153 A CA 2000153A CA 2000153 A1 CA2000153 A1 CA 2000153A1
Authority
CA
Canada
Prior art keywords
antidote
factor viii
blood
fragments
retain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2000153A
Other languages
English (en)
Other versions
CA2000153C (fr
Inventor
Valerie S. Findlay
Roger Kerry
Graham F. Pay
Robert B. Wallis
Keith D. Butler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10644806&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2000153(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of CA2000153A1 publication Critical patent/CA2000153A1/fr
Application granted granted Critical
Publication of CA2000153C publication Critical patent/CA2000153C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Dental Preparations (AREA)
  • Materials Applied To Surfaces To Minimize Adherence Of Mist Or Water (AREA)
  • Saccharide Compounds (AREA)
  • External Artificial Organs (AREA)
CA002000153A 1988-10-06 1989-10-04 Antidote Expired - Fee Related CA2000153C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8823480.2 1988-10-06
GB888823480A GB8823480D0 (en) 1988-10-06 1988-10-06 Antidote

Publications (2)

Publication Number Publication Date
CA2000153A1 true CA2000153A1 (fr) 1990-04-06
CA2000153C CA2000153C (fr) 1999-07-13

Family

ID=10644806

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002000153A Expired - Fee Related CA2000153C (fr) 1988-10-06 1989-10-04 Antidote

Country Status (13)

Country Link
EP (1) EP0367713B2 (fr)
JP (1) JPH02145526A (fr)
KR (1) KR0147294B1 (fr)
AT (1) ATE77752T1 (fr)
AU (1) AU624635B2 (fr)
CA (1) CA2000153C (fr)
DE (1) DE68901964T2 (fr)
DK (1) DK491289A (fr)
GB (1) GB8823480D0 (fr)
IE (1) IE61361B1 (fr)
IL (1) IL91886A (fr)
NZ (1) NZ230899A (fr)
ZA (1) ZA897586B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL99527A (en) * 1990-09-28 1997-08-14 Lilly Co Eli Tripeptide antithrombotic agents
WO1994008034A1 (fr) * 1992-09-28 1994-04-14 Japan Energy Corporation Nouvelle variante d'hirudine, son procede de production, et anticoagulant la contenant comme ingredient actif
US5972648A (en) * 1993-09-28 1999-10-26 Japan Energy Corporation Hirudin analogs, methods of manufacture thereof and anticoagulant compositions having these as active ingredients
DE4430205A1 (de) * 1994-08-26 1996-02-29 Behringwerke Ag Zusammensetzungen, die als Gegenmittel für Blut-Antikoagulanzien geeignet sind und deren Verwendung
DE4437544A1 (de) * 1994-10-20 1996-04-25 Behringwerke Ag Einsatz von vWF-enthaltenden Konzentraten als Kombinationstherapie bei Therapie mit Antithrombotika und Fibrinolytika

Also Published As

Publication number Publication date
IE893212L (en) 1990-04-06
AU624635B2 (en) 1992-06-18
EP0367713B1 (fr) 1992-07-01
DK491289A (da) 1990-04-07
DK491289D0 (da) 1989-10-05
DE68901964D1 (de) 1992-08-06
JPH02145526A (ja) 1990-06-05
IE61361B1 (en) 1994-11-02
AU4266289A (en) 1990-04-12
DE68901964T2 (de) 1995-06-14
KR0147294B1 (ko) 1998-08-17
IL91886A (en) 1995-07-31
NZ230899A (en) 1991-10-25
CA2000153C (fr) 1999-07-13
ATE77752T1 (de) 1992-07-15
EP0367713B2 (fr) 1995-01-04
IL91886A0 (en) 1990-06-10
KR900005992A (ko) 1990-05-07
EP0367713A1 (fr) 1990-05-09
ZA897586B (en) 1990-05-30
GB8823480D0 (en) 1988-11-16

Similar Documents

Publication Publication Date Title
DE68905249D1 (de) Blutbehaelter.
DK157690D0 (da) Pedikelaktiveringsorgan
DE3861517D1 (de) Blutdruckueberwacher.
DE69008664D1 (de) Bestrahlung von bluterzeugnissen.
AU570175B2 (en) Blood microcollection assembly
DE3854424D1 (de) Medizinisches Instrument.
AU1072988A (en) Anticoagulant peptides
AU2885589A (en) Composition of anticoagulants
AU1103288A (en) Hemolysis depressent and blood preserving composition
CA2070647A1 (fr) Utilisation d'un anticoagulant comme agent diagnostique
DE68919964D1 (de) Biomedizinische Elektrodenanordnung.
DE68910100D1 (de) Mittel zur Bluttrennung.
AU4039289A (en) Biological disc
CA2000153A1 (fr) Antidote
DK109590D0 (da) Biologisk aktivt protein
IT8821300A0 (it) Procedimento di preparazione di morniflumato e analoghi.
DK191089A (da) Biologisk aktive forbindelser
AU3843289A (en) Blood substitute
IT8519190A0 (it) Procedimento per la lavorazione di residui contenenti nichel e vanadio.
EP0331743A4 (fr) Proteine derivee d'un corps vivant.
IT1228559B (it) Procedimento per la preparazione di enzima mieloperossidasi.
ZA882192B (en) Vascular anticoagulant proteins
AU6095990A (en) Anticoagulant peptides
NO880613L (no) Blodprodukter.
BR6800254U (pt) Perfumador e/ou desodorizador

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed